Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities

Go back to Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities
(NASDAQ: PSNL) Delayed: 15.88 --0 (-0%)
Previous Close $15.88    52 Week High $ 
Open $15.88    52 Week Low $ 
Day High $15.88    P/E N/A 
Day Low $15.88    EPS $ 
Volume 215